<正> The effects of nimodipine on platelet aggregation and arachidonic acid(AA)metabolismwere studied in order to explore its effect on patients with thrombosis or cardiovas-cular disease.The results indicate that nimodipine(50-350μmol/L)significantly inhibitsplatelet aggregation induced by ADP,AA,and ionophore A23187 in a dose dependentmanner.The inhibitory effects induced by ionophore A23187 could be partially antagonizedby calcium(1 mmol/L).When the substrate was AA and the enzyme was supplied bypig lung microsomes,nimodipine(50-400μmol/L)significantly reduced the generation ofTXB2 and 6-keto-PGF1a in parallel.When the substrate was prostaglandin endoperoxide,however,the levels of TXB2 and 6-keto-PGF1awere not significantly altered in the sameconcentration range.The results suggest that nimodipine is a cyclooxygenase inhibitor,andits ability to inhibit platelet aggregation is related to its calcium blocking effect.